We fully realize that the regulation of PARP-1 in myoblasts and myotubes may be a specialized case since PARP-1 has multiple roles in a variety of cell types, ranging from cancer cell survival to an active factor mediating necrosis in parenchymal cells, and catalyzing pro-inflammatory gene expression in immune cells [1–3]. The gene discussed is PARP1; the disease is cancer.